Skip to main content
. 2013 Dec 1;27(12):669–680. doi: 10.1089/apc.2013.0208

Table 1.

Studies Summarized in the Review of the Reproductive Health Behaviors of HIV-Infected Young Women in the USa

Citation
Sections cited in
Study design and sample characteristics
Lead author, year, reference number Sexual activity Relationships Disclosure Pregnancy intention Contraceptive use Condom use Study design Study source (recruitment dates) Analytic sample PHIV, BHIV, or both Includes HIV-uninfected comparison group?
Batterham (2005) [48]
 
 
X
 
 
 
Cross-sectional analysis of survey data
Clinical care sites in 4 cities (2 cohorts, 1994–1996 and 1999–2000)
Ages 13–24 years (N=351 and N=253); 28%/30% female (Pre-HAART/Post-HAART)
Not noted, but included many BHIV
No
Bauermeister (2009) [36]
X
 
 
 
 
 
Cross-sectional analysis of survey data, medical chart abstractions of HIV+study participants
Project Child and Adolescent Self-Awareness and Health Project (CASAH), 4 clinical care sites in 1 city (2003–2007)
Ages 9–16 years, N=316, 50% female, 60% HIV+
PHIV
Yes
Bauermeister (2012) [37] & Elkington (2012) [38]
X
 
 
 
 
X
Longitudinal analysis of survey data
Combined sample using Risk and Resilience in Youth With HIV+Mothers (R&R, 1998–2000) and CASAH (2003–2005)
Ages 9–16 years, Combined sample N=417 and 420, respectively, 50% female, 39% HIV+
PHIV
Yes
Belzer (2001)
[25]
 
 
 
 
X
 
Cross-sectional analysis of survey data
REACH study (1996–1999)
Ages 13–18 years old, N=216 participants with 648 study visits, 100% female, 66% HIV+
BHIV
Yes
Clum (2009)
[8]
 
X
 
 
 
 
Qualitative study
3 ATN sites (year not noted)
Ages 18–24 years, N=40, 100% female
BHIV
No
Clum (2012)
[19]
 
X
 
 
 
X
Cross-sectional analysis of survey data
5 ATN sites (2003–2004)
Ages 18–24 years, N=118, 100% female
BHIV
No
D'Angelo (2001)
[26]
 
 
X
 
 
 
Cross-sectional analysis of survey data, lab studies, chart review
REACH study (1996–1999)
Ages 14–19 years, N=203, 70% female
BHIV
No
Dempsey (2012)
[20]
 
X
X
 
 
X
Cross-sectional analysis of survey data
5 ATN sites (2005–2006)
Ages 16–24 years, N=146, 48% female
Both (87% BHIV)
No
Ezeanoule (2006)
[41]
 
 
 
X
 
 
Cross-sectional analysis of survey data
FXB clinic, University of Medicine & Dentistry of NJ (2003–2004)
Ages 13–24 years, N=57, 100% female
PHIV
No
Fair (2012) [35]
 
X
X
 
 
 
Qualitative study
2 clinics (2011–2012)
Ages 15–30 (mean 20.7 years), N=35, 66% female
PHIV
No
Finger (2012)
[9]
 
 
 
X
 
 
Cross-sectional analysis of survey data
5 ATN sites (2003–2004)
Ages 13–24 years, N=130, 100% female
BHIV
No
Finocchario-Kessler (2012) [39]
 
 
 
X
 
 
Cross-sectional analysis of survey data
Combined sources: Neighborhood Influences on Adolescent and Adult Health (NIAAH) household- based survey+convenience sample of patients from 1 clinical care site (2004–2008)
Ages 15–24 years, N=401, 100% female, 11% HIV+
Both (44% PHIV)
Yes
Jennings (2009)
[21]
 
X
 
 
 
 
Cross-sectional analysis of survey data
15 ATN sites (2003–2004)
Ages 13–24 years, N=176, 100% female (sample of 177 MSM also surveyed)
BHIV
No
Koenig (2007)
[14]
 
X
 
X
 
 
Cross-sectional analysis of survey data and chart abstraction
Perinatal Guidelines Evaluation Project, 4 sites (1997–1999)
Ages 13–21 years, N=147, 100% female, 42% HIV+
BHIV
Yes
Koenig (2010)
[29]
X
 
X
 
 
X
Cross-sectional analysis of survey data, chart review
Adolescent Impact Study, 5 clinics in 3 cities (2002–2005)
Age 13–21 years, N=166, 53% female
Both (60% PHIV)
No
Lam (2007)
[46]
 
 
X
 
 
 
Cross-sectional analysis of survey data, chart review
1 urban site (2002–2003)
Ages 16–25 years, N=66, 49% female
Not stated
No
Leonard (2010)
[34]
 
 
X
 
 
 
Qualitative study
HIV clinics in 1 urban area (2007)
Ages 13–24 years, N=20, 75% female
Both (60% PHIV)
No
Marhefka (2011)
[33]
 
X
 
 
 
X
Qualitative study
Clinical care site in 1 city (year not noted)
Ages 12–16 years, N=20, 100% female
PHIV
No
Massad (2007)
[31]
 
 
 
 
X
 
Longitudinal analysis of survey data
Women's Interagency HIV Study or WIHS (1994–2005)
Ages<20 to over 50 years, total sample=2784 with 71 women under age 20, 100% female, 31% of women under age 20 were HIV+
Not noted but 75% BHIV
Yes
Mellins (2011)
[40]
X
 
 
 
 
X
Cross-sectional analysis of survey data
Pediatric HIV/ AIDS Cohort Study or PHACS, 15 sites (2007–2010)
Ages 10–16 years, N=349, 50% female, 68% HIV+
PHIV
Yes
Murphy (2001)
[27]
X
 
 
 
 
X
Longitudinal analysis of survey data
REACH study (1996–1999)
Youth mean age 17 (SD 1.1), N=323, 74% female
BHIV
No
Nugent (2010)
[22]
 
 
 
 
 
X
Cross-sectional analysis of survey data
5 ATN sites (year not noted)
Ages 16–24 years, N=122, 43% female
Not noted but likely many BHIV
No
O'Brien (2003)
[47]
 
 
X
 
 
 
Cross-sectional analysis of survey data
2 clinical care sites in 1 city (2000)
Ages 18 and older, N=269 overall, N=28 for those ages 18–22 years, 48% female
Both but mostly PHIV (91%)
No
Orban (2010)
[30]
 
 
X
 
 
 
Cross-sectional analysis of survey data, chart review
Adolescent Impact Study, 5 clinics in 3 cities (2002–2005)
Ages 13–21 years, N=166, 53% female
Both (60% PHIV)
No
Outlaw (2010)
[23]
 
 
 
 
 
X
Cross-sectional analysis of survey data
4 ATN sites and 1 one non-ATN site (year not noted)
Ages 16–24 years, N=186, 48% female
Both (83% BHIV)
No
Setse (2011)
[32]
X
 
 
 
 
 
Chart abstraction, one point in time
Longitudinal Epidemiologic Study to Gain Insight into HIV/AIDS in Children and Youth or LEGACY, 22 cities (2006)
Ages 13– 24 years, N=752, 56% female
Both (76% PHIV)
No
Sturdevant (2001) [28]
 
X
X
 
 
X
Cross-sectional analysis of survey data
REACH study (1996–1999)
Ages 13–19 years, N=243, 100% female, 63% HIV+
BHIV
Yes
Tanney (2010)
[24]
 
 
 
 
 
X
Cross-sectional analysis of survey data
4 ATN sites+1 non-ATN site (year not noted)
Youth with mean age 20.4 (SD 2.46), N=352 (screener data), 42% female
Both (80% BHIV)
No
Wiener (2006)
[42]
 
 
X
 
 
 
Cross-sectional analysis of survey data, chart review
Patients seen at 1 National Cancer Institute clinical care site (2003)
Ages 13–24 years, N=40, 62% female
PHIV or tranfusion-infected only
No
Total: 7 8 11 4 2 11          
a

Two additional review articles are not included in this table: Koenig 2011 [16] and Eustace 2010 [15].

BHIV, Behaviorally-infected youth; HAART, Highly-active anti-retroviral therapy; PHIV, Perinatally-infected youth.